Lemonaid Health vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Willow beats Lemonaid Health overall, scoring 8.2/10 vs 7.2/10. Lemonaid Health is more affordable at $248/mo vs $299/mo. Choose Lemonaid Health for users who want a flexible membership with broad medication o. Choose Willow for users who want comprehensive clinical support with flexibili.

A side-by-side comparison of Lemonaid Health and Willow covering pricing, scores, medication types, insurance, and more to help you decide.

Lemonaid Health

#43 of 48

7.2/10

Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).

Visit Lemonaid Health

Higher Rated

Willow

#8 of 48

8.2/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Lemonaid Health	Willow
Our Score	7.2/10	8.2/10
Starting Price	$248/mo	$299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449)	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Ranking	#43	#8

Pros & Cons Compared

Lemonaid Health

Pros

+2026 restructure — $49/mo Weight Loss Membership (replaces the old $25/visit model)
+6-month plan discount — compounded tirzepatide drops to $229/mo on a 6-month commitment
+Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
+Established since 2013 with physician-only prescribing and rigorous intake

Cons

−Membership and medication billed separately — the $49/mo number is just the membership, not all-in
−Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high — read as access, not value
−Best compounded pricing requires a 6-month commitment
−The 23andMe acquisition created some uncertainty about the platform's long-term focus

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only — no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
−Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024 — less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Lemonaid Health with a score of 8.2/10 vs 7.2/10. If budget is your priority, Lemonaid Health starts at $248/mo compared to Willow's $299/mo. Lemonaid Health offers both brand-name and compounded medications, giving you more flexibility. Choose Lemonaid Health if you want: users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449). Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Lemonaid Health nor Willow feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review